Skip to content Skip to navigation
University of Warwick
  • Study
  • |
  • Research
  • |
  • Business
  • |
  • Alumni
  • |
  • News
  • |
  • About

University of Warwick
Publications service & WRAP

Highlight your research

  • WRAP
    • Home
    • Search WRAP
    • Browse by Warwick Author
    • Browse WRAP by Year
    • Browse WRAP by Subject
    • Browse WRAP by Department
    • Browse WRAP by Funder
    • Browse Theses by Department
  • Publications Service
    • Home
    • Search Publications Service
    • Browse by Warwick Author
    • Browse Publications service by Year
    • Browse Publications service by Subject
    • Browse Publications service by Department
    • Browse Publications service by Funder
  • Help & Advice
University of Warwick

The Library

  • Login
  • Admin

Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer

Tools
- Tools
+ Tools

Stonelake, P. S., Bundred, N. J., Neoptolemos, N. P., Baker, P. R., Baker, P. G., Gillespie, W. M., Dunn, Janet A., Spooner, D., Morrison, J. M., Bundred, N. J., Oates, G. D., Stonelake, P. S., Lee, M. J. R., Neoptolemos, J. P. and Chan, S. Y. (1994) Steroid receptors, pS2 and cathepsin D in early clinically node-negative breast cancer. European Journal of Cancer Care, 30 (1). pp. 5-11. doi:10.1016/S0959-8049(05)80008-5

Research output not available from this repository, contact author.
Official URL: https://doi.org/10.1016/S0959-8049(05)80008-5

Request Changes to record.

Abstract

Four oestrogen-regulated proteins of reported prognostic value, oestrogen receptor (ER), progesterone receptor (PR), pS2 and cathepsin D (Cat D), have been quantified by immunoassays, and the latter studied by immunohistochemistry (IHC) in primary tumours from clinically node-negative early breast cancer patients, entered into a trial of breast conservation therapy in which all the patients received adjuvant tamoxifen. ER, PR and pS2 significantly co-correlated but none correlated with Cat D. ER, PR and pS2, but not Cat D, were significantly associated with tumour size and grade, although Cat D tended to show an inverse relationship with the latter. Cat D (radioimmunoassay) in pmol/mg significantly correlated with the IHC score for Cat D in carcinoma cells as well as the number of Cat D-expressing macrophages. At a median follow-up of only 16 months, recurrence was significantly more common in patients with tumours having negative status for ER, PR and pS2 but was not associated with Cat D status.

Item Type: Journal Article
Subjects: R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer)
Divisions: Faculty of Medicine > Warwick Medical School > Health Sciences > Clinical Trials Unit
Faculty of Medicine > Warwick Medical School > Health Sciences
Faculty of Medicine > Warwick Medical School
Journal or Publication Title: European Journal of Cancer Care
Publisher: Wiley-Blackwell Publishing Ltd.
ISSN: 0961-5423
Official Date: 1994
Dates:
DateEvent
1994Published
27 September 1993Accepted
Volume: 30
Number: 1
Page Range: pp. 5-11
DOI: 10.1016/S0959-8049(05)80008-5
Status: Peer Reviewed
Publication Status: Published
Access rights to Published version: Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item View Item
twitter

Email us: wrap@warwick.ac.uk
Contact Details
About Us